These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2131040

  • 1. A suramin derivative induces enterocyte-like differentiation of human colon cancer cells without lysosomal storage disorder.
    Baghdiguian S, Nickel P, Marvaldi J, Fantini J.
    Anticancer Drugs; 1990 Oct; 1(1):59-66. PubMed ID: 2131040
    [Abstract] [Full Text] [Related]

  • 2. [Suramin induces lysosomal storage disorder in HT29-D4 cells during a mechanism of polarized endocytosis].
    Baghdiguian S, Boudier JA, Verrier B, Zappitelli JP, Fantini J.
    C R Acad Sci III; 1992 Oct; 314(2):67-73. PubMed ID: 1559184
    [Abstract] [Full Text] [Related]

  • 3. Kinetics of biochemical, electrophysiological and morphological events (including lysosomal disorder) during the course of suramin-induced differentiation of the human colon-cancer cell clone HT29-D4.
    Baghdiguian S, Verrier B, Marvaldi J, Fantini J.
    Int J Cancer; 1991 Oct 21; 49(4):608-15. PubMed ID: 1917163
    [Abstract] [Full Text] [Related]

  • 4. Double screening of suramin derivatives on human colon cancer cells and on neural cells provides new therapeutic agents with reduced toxicity.
    Baghdiguian S, Nickel P, Fantini J.
    Cancer Lett; 1991 Dec 01; 60(3):213-9. PubMed ID: 1756511
    [Abstract] [Full Text] [Related]

  • 5. Short-term suramin treatment followed by the removal of the drug induces terminal differentiation of HT29-D4 cells.
    Baghdiguian S, Verrier B, Marvaldi J, Fantini J.
    J Cell Physiol; 1992 Jan 01; 150(1):168-74. PubMed ID: 1730780
    [Abstract] [Full Text] [Related]

  • 6. Impaired carcinoembryonic antigen release during the process of suramin-induced differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
    Fantini J, Rognoni JB, Theveniau M, Pommier G, Marvaldi J.
    J Cell Physiol; 1990 Jun 01; 143(3):468-74. PubMed ID: 2162847
    [Abstract] [Full Text] [Related]

  • 7. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
    Pommier GJ, Garrouste FL, el Atiq F, Roccabianca M, Marvaldi JL, Remacle-Bonnet MM.
    Cancer Res; 1992 Jun 01; 52(11):3182-8. PubMed ID: 1375536
    [Abstract] [Full Text] [Related]

  • 8. Insulin like growth factor I is an autocrine regulator of human colon cancer cell differentiation and growth.
    Baghdiguian S, Verrier B, Gerard C, Fantini J.
    Cancer Lett; 1992 Feb 14; 62(1):23-33. PubMed ID: 1311629
    [Abstract] [Full Text] [Related]

  • 9. The concentration of glucose in the culture medium determines the effect of suramin on the growth and differentiation of the human colonic adenocarcinoma cell clone HT29-D4.
    Rabenandrasana C, Baghdiguian S, Roccabianca M, Brunet M, Marvaldi J, Fantini J.
    Cancer Lett; 1990 Sep 14; 53(2-3):109-15. PubMed ID: 2208069
    [Abstract] [Full Text] [Related]

  • 10. Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4.
    Fantini J, Rognoni JB, Roccabianca M, Pommier G, Marvaldi J.
    J Biol Chem; 1989 Jun 15; 264(17):10282-6. PubMed ID: 2656707
    [Abstract] [Full Text] [Related]

  • 11. Co-localization of suramin and serum albumin in lysosomes of suramin-treated human colon cancer cells.
    Baghdiguian S, Boudier JA, Boudier JL, Fantini J.
    Cancer Lett; 1996 Mar 29; 101(2):179-84. PubMed ID: 8620467
    [Abstract] [Full Text] [Related]

  • 12. Suramin-induced differentiation of the human colic adenocarcinoma cell clone HT29-D4 in serum-free medium.
    Fantini J, Verrier B, Robert C, Pic P, Pichon J, Mauchamp J, Marvaldi J.
    Exp Cell Res; 1990 Jul 29; 189(1):109-17. PubMed ID: 2161345
    [Abstract] [Full Text] [Related]

  • 13. Autoradiographic localization of tritiated suramin in polarized human colon adenocarcinoma cells.
    Baghdiguian S, Boudier JA, Boudier JL, Fantini J.
    Cancer Lett; 1993 Dec 20; 75(3):151-6. PubMed ID: 8313350
    [Abstract] [Full Text] [Related]

  • 14. [Suramin inhibits the proliferation and stimulates the differentiation of tumoral cell lines HT29-D4 and C6].
    Baghdiguian S, Pichon J, Marvaldi J, Fantini J.
    Bull Cancer; 1991 Dec 20; 78(9):807-17. PubMed ID: 1751832
    [Abstract] [Full Text] [Related]

  • 15. Differentiation-inducing effect of retinoic acid, difluoromethylornithine, sodium butyrate and sodium suramin in human colon cancer cells.
    Reynolds S, Rajagopal S, Chakrabarty S.
    Cancer Lett; 1998 Dec 11; 134(1):53-60. PubMed ID: 10381130
    [Abstract] [Full Text] [Related]

  • 16. Suramin-treated HT29-D4 cells grown in the presence of glucose in permeable culture chambers form electrically active epithelial monolayers. A comparative study with HT29-D4 cells grown in the absence of glucose.
    Fantini J, Rognoni JB, Verrier B, Lehmann M, Roccabianca M, Mauchamp J, Marvaldi J.
    Eur J Cell Biol; 1990 Feb 11; 51(1):110-9. PubMed ID: 2328732
    [Abstract] [Full Text] [Related]

  • 17. Intracellular localisation of suramin, an anticancer drug, in human colon adenocarcinoma cells: a study by quantitative autoradiography.
    Baghdiguian S, Boudier JL, Boudier JA, Fantini J.
    Eur J Cancer; 1996 Mar 11; 32A(3):525-32. PubMed ID: 8814702
    [Abstract] [Full Text] [Related]

  • 18. [The in vitro differentiation of cancer cells of the human colon (HT29-D4) is associated with the presence of annulate lamellae in the basal part of the cytoplasm].
    Baghdiguian S, Fantini J.
    C R Acad Sci III; 1990 Mar 11; 311(10):347-52. PubMed ID: 2125845
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.